Uriflo-D

Ravenbhel Healthcare Private Limited🇵🇭 Food and Drug Administration - Philippines

Approval Id: 33fdb8f9065b7071
Drug Approval Philippines Name: Uriflo-D
Product Name: Uriflo-D
Registration Number: DRP-12159
Brand Name: Uriflo-D
Generic Name: Dutasteride + Tamsulosin Hydrochloride
Dosage Form: Capsule
Dosage Strength: 500 mcg/400 mcg
Manufacturer: Ravenbhel Healthcare Private Limited
Importer: Khriz Pharma Trading Inc.
Distributor: Khriz Pharma Trading Inc.
Issuance Date: 24 June 2022
Expiry Date: 24 June 2027
Pharmacologic Category: Drugs Used in Benign Prostatic Hypertrophy (Alpha-adrenoreceptor antagonist)
Classification: Prescription Drug (RX)

Approved

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

33fdb8f9065b7071

Type

Standard